The UK government is expanding access to naloxone (an opioid overdose reversal medication) through take-home kits and emergency supply schemes, led by the Department of Health and Social Care and devolved administrations. The policy aims to reduce fatal overdoses, particularly among people leaving custody, and includes proposals for universal rollout coupled with training. Current status involves government response to consultation proposals and implementation planning across England, Scotland, Wales, and Northern Ireland.
This consultation seeks views on proposals to make further legislative changes to expand access to take-home naloxone supplies and naloxone for emergency use.
This consultation seeks views on proposals to make further legislative changes to expand access to take-home naloxone supplies and naloxone for emergency use.
Seeks views on extending the range of medicines available to optometrists and contact lens opticians so they can treat minor eye conditions in the community.
Seeks views on extending the range of medicines available to optometrists and contact lens opticians so they can treat minor eye conditions in the community.
In response to: Proposals to expand access to take-home naloxone supplies
In response to: Proposals to expand access to take-home naloxone supplies
The UK Government is consulting on proposed legislative amendments to widen access to take-home supplies of naloxone, without a prescription.
The UK Government is consulting on proposed legislative amendments to widen access to take-home supplies of naloxone, without a prescription.
The UK Government is consulting on proposed legislative amendments to widen access to take-home supplies of naloxone, without a prescription.
In response to: Expanding access to naloxone
In response to: Expanding access to naloxone
This consultation collected views on expanding the use of naloxone. It ran for 8 weeks and was open to all interested individuals and organisations.
This consultation collected views on expanding the use of naloxone. It ran for 8 weeks and was open to all interested individuals and organisations.
This consultation collected views on expanding the use of naloxone. It ran for 8 weeks and was open to all interested individuals and organisations.
Seeks views on proposals to change legislation to allow schools to choose to hold spare adrenaline auto-injectors (AAIs) for emergencies.
Seeks views on proposals to change legislation to allow schools to choose to hold spare adrenaline auto-injectors (AAIs) for emergencies.
Seeks views on proposals to change legislation to allow schools to choose to hold spare adrenaline auto-injectors (AAIs) for emergencies.
Seeks comments on electronically prescribing Schedules 2 and 3 Controlled Drugs (CDs) both in the NHS and privately.
Seeks comments on electronically prescribing Schedules 2 and 3 Controlled Drugs (CDs) both in the NHS and privately.
Seeks comments on electronically prescribing Schedules 2 and 3 Controlled Drugs (CDs) both in the NHS and privately.